| Effectiveness and safety of dabigatran and warfarin in real‐world US patients with non‐valvular atrial fibrillation: a retrospective cohort study JC Lauffenburger, JF Farley, AK Gehi, DH Rhoney, MA Brookhart, G Fang Journal of the American Heart Association 4 (4), e001798, 2015 | 194 | 2015 |
| Racial/ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction JC Lauffenburger, JG Robinson, C Oramasionwu, G Fang Circulation 129 (7), 754-763, 2014 | 153 | 2014 |
| Health literacy and 30-day hospital readmission after acute myocardial infarction SC Bailey, G Fang, IE Annis, R O'Conor, MK Paasche-Orlow, MS Wolf BMJ open 5 (6), e006975, 2015 | 121 | 2015 |
| Adherence tradeoff to multiple preventive therapies and all-cause mortality after acute myocardial infarction MJ Korhonen, JG Robinson, IE Annis, RP Hickson, JS Bell, J Hartikainen, ... Journal of the American College of Cardiology 70 (13), 1543-1554, 2017 | 89 | 2017 |
| Factors driving anticoagulant selection in patients with atrial fibrillation in the United States JC Lauffenburger, JF Farley, AK Gehi, DH Rhoney, MA Brookhart, G Fang The American journal of cardiology 115 (8), 1095-1101, 2015 | 75 | 2015 |
| Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy JC Lauffenburger, DH Rhoney, JF Farley, AK Gehi, G Fang Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (6 …, 2015 | 59 | 2015 |
| Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data G Fang, JM Brooks, EA Chrischilles American journal of epidemiology 175 (1), 60-65, 2012 | 51 | 2012 |
| Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: A systematic review and meta-analysis H Alwafi, AA Alsharif, L Wei, D Langan, AY Naser, P Mongkhon, JS Bell, ... diabetes research and clinical practice 170, 108522, 2020 | 47 | 2020 |
| Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication G Fang, JM Brooks, EA Chrischilles American journal of epidemiology 175 (11), 1142-1151, 2012 | 47 | 2012 |
| Outcomes-based Pharmacist Reimbursement: Reimbursing Pharmacists for Cognitive Services (Part 1 of a 2-part series) K Farris Journal of Managed Care Pharmacy 8 (5), 383-393, 2002 | 47 | 2002 |
| Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis RJ Desai, JK Rao, RA Hansen, G Fang, ML Maciejewski, JF Farley Journal of Managed Care Pharmacy 20 (11), 1110-1120, 2014 | 46 | 2014 |
| Opening the black box of the group‐based trajectory modeling process to analyze medication adherence patterns: an example using real‐world statin adherence data RP Hickson, IE Annis, LA Killeya‐Jones, G Fang Pharmacoepidemiology and drug safety 29 (3), 357-362, 2020 | 45 | 2020 |
| Changes in statin adherence following an acute myocardial infarction among older adults: patient predictors and the association with follow‐up with primary care providers and … RP Hickson, JG Robinson, IE Annis, LA Killeya‐Jones, MJ Korhonen, ... Journal of the American Heart Association 6 (10), e007106, 2017 | 41 | 2017 |
| Survival implications associated with variation in mastectomy rates for early‐staged breast cancer JM Brooks, EA Chrischilles, MB Landrum, KB Wright, G Fang, EP Winer, ... International journal of surgical oncology 2012 (1), 127854, 2012 | 40 | 2012 |
| A new method to isolate local-area practice styles in prescription use as the basis for instrumental variables in comparative effectiveness research G Fang, JM Brooks, EA Chrischilles Medical care 48 (8), 710-717, 2010 | 34 | 2010 |
| Interpreting treatment-effect estimates with heterogeneity and choice: simulation model results JM Brooks, G Fang Clinical therapeutics 31 (4), 902-919, 2009 | 34 | 2009 |
| Hospital admissions due to dysglycaemia and prescriptions of antidiabetic medications in England and Wales: an ecological study AY Naser, Q Wang, LYL Wong, J Ilomaki, JS Bell, G Fang, ICK Wong, ... Diabetes Therapy 9, 153-163, 2018 | 32 | 2018 |
| Tumor necrosis factor-α inhibitor treatment and the risk of incident cardiovascular events in patients with early rheumatoid arthritis: a nested case-control study RJ Desai, JK Rao, RA Hansen, G Fang, M Maciejewski, J Farley The Journal of Rheumatology 41 (11), 2129-2136, 2014 | 31 | 2014 |
| Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence … MA Ward, G Fang, KL Richards, CM Walko, SR Earnshaw, LE Happe, ... Current Medical Research and Opinion 31 (2), 289-297, 2015 | 28 | 2015 |
| Population-based medication reviews: a descriptive analysis of the medication issues identified in a Medicare not-for-profit prescription discount program KB Farris, JM Ganther-Urmie, G Fang, WR Doucette, JM Brooks, ... Annals of Pharmacotherapy 38 (11), 1823-1829, 2004 | 25 | 2004 |
